Senores Pharmaceuticals Ltd (Senores), a research-focused generics manufacturer, reported 86% jump in revenue in FY24-25, ...

Institutional demand has been fuelling Bitcoin’s comeback, potentially shifting crypto from speculation to strategic investment.

Transatlantic dealmaking is reshaping the UK’s corporate landscape, as global firms capitalise on an opportunity to improve ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Welcome to Ask the analyst, where I put questions from Morningstar readers (and myself) to members of our equity research team. If you have a question about an ASX company or industry that we cover, ...

What's more, as the U.S. IPO market heats back up, more of these deals could follow, said Angelo Bochanis, an analyst at Renaissance Capital, a provider of pre-IPO research and IPO-focused ETFs.

Discover how to buy Bitgo pre-IPO shares, its funding history, valuation, and what makes this institutional crypto leader worth watching.

In just three years, a medium-sized market town has cracked a code that's eluded community development experts for decades. The Didcot Powerhouse Fund has delivered £400,000 in grants to nearly 9,000 ...

IN RECENT weeks, two relatively large initial public offers (IPOs) were announced: NTT’s data centre real estate investment ...

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

The Jackson Hole Conference is where top-tier economists and central bankers discuss challenges facing the global economy.

Chowdhury believes the challenge can be met with “clever” solutions at every level, from the physical hardware to the AI software itself. For example, his lab has developed algorithms that calculate ...